CanadaBis Capital (CANB) AI Stock Analysis

• Market Cap: C$6.22M
• Dividend Yield: N/A
• Average Volume (3M): 163.57K
• Price to Earnings (P/E): 30.0
• Beta (1Y): -0.31
• Revenue Growth: -14.41%
• EPS Growth: -93.67%
• Country: CA
• Employees: N/A
• Sector: Financial
• Sector Strength: 83
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 138,256,380
• 10 Day Avg. Volume: 50,756
• 30 Day Avg. Volume: 163,574
• PEG Ratio: -5.14
• Price to Book (P/B): 0.82
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -14.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 53 Neutral
• Price Target: C$0.00 ▼(-100.00%Downside)

CanadaBis Capital, Inc. is facing significant financial challenges, particularly in cash flow and profitability, which negatively impact its stock score. Bearish technical indicators also contribute to the lower score. Recent corporate events, including significant financing and improved quarterly results, provide some positive momentum, but are not sufficient to offset the broader financial and technical concerns.

CanadaBis Capital Business Overview & Revenue Model

Company Description

CanadaBis Capital, Inc. (CANB) is a Canadian company operating within the cannabis sector. The company is focused on the production and distribution of cannabis products, leveraging its vertically integrated operations to supply both medical and recreational markets. CanadaBis Capital aims to deliver high-quality cannabis products while maintaining a strong commitment to sustainability and innovation.

How the Company Makes Money

CanadaBis Capital, Inc. generates revenue primarily through the cultivation, production, and sale of cannabis products. The company operates a vertically integrated business model, which means it controls the entire supply chain from cultivation to distribution. This allows CanadaBis to produce various cannabis products, including dried flower, oils, and edibles, for both medical and recreational consumers. Revenue streams include direct sales to consumers, wholesale agreements with dispensaries and retailers, and possibly partnerships with other companies in the cannabis industry to expand its market reach. Additionally, the company's focus on innovation and quality helps it maintain a competitive edge, potentially leading to higher sales and market share.

CanadaBis Capital Financial Statement Overview

Summary

CanadaBis Capital, Inc. faces financial challenges, particularly in cash flow management and profitability. The gross profit margin is healthy, but the net profit margin is low, and revenue has been declining. Balance sheet strengths are partially offset by high debt levels, and negative cash flow indicates liquidity issues.

Income Statement

CanadaBis Capital, Inc. shows a mixed performance on the income statement. The gross profit margin for TTM is approximately 47.5%, indicating efficient production cost management relative to revenue. However, the net profit margin is low at 1.1%, reflecting challenges in controlling operating expenses or other costs. Revenue has decreased over the past year, with the most recent TTM revenue at $17.89 million compared to $22.22 million two years prior, showing a negative growth trajectory. EBIT and EBITDA margins are also relatively low, signaling limited operating profitability.

Balance Sheet

The balance sheet presents a moderately stable financial structure. The debt-to-equity ratio for TTM stands at approximately 0.71, which is somewhat high and suggests a reliance on debt financing. The return on equity (ROE) is low at 2.4%, indicating limited efficiency in generating profits from shareholders' equity. However, the equity ratio is at a solid 33%, suggesting a reasonable proportion of assets financed by equity, providing a buffer against liabilities.

Cash Flow

The cash flow statement reveals challenges in liquidity management. The operating cash flow to net income ratio is negative, as the company reported a negative operating cash flow of -$176,696 for the TTM, indicating difficulties in converting sales to actual cash. Free cash flow is also negative and has decreased over time, from $4.57 million two years ago to -$480,187 in the latest TTM, highlighting cash flow constraints and potential issues with sustaining operations without external funding.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
17.89M	17.95M	22.22M	11.67M	6.87M	4.43M
	Gross Profit
8.50M	8.82M	11.78M	5.57M	2.52M	1.16M
	EBIT
528.75K	833.78K	4.68M	1.04M	-2.29M	-4.72M
	EBITDA
1.64M	2.09M	5.68M	1.63M	-1.81M	-4.43M
	Net Income Common Stockholders
201.75K	600.28K	4.44M	608.33K	-2.68M	-5.39M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.40M	1.68M	3.23M	144.88K	849.50K	167.00K
	Total Assets
23.49M	24.55M	22.96M	15.48M	13.28M	12.52M
	Total Debt
6.38M	6.44M	7.31M	7.82M	8.44M	6.06M
	Net Debt
4.69M	4.76M	4.08M	7.67M	7.59M	5.89M
	Total Liabilities
15.21M	16.45M	15.62M	12.84M	11.46M	9.09M
	Stockholders Equity
8.19M	8.00M	7.25M	2.54M	1.73M	3.34M
Cash Flow		Free Cash Flow
-480.19K	-594.48K	4.57M	-292.54K	-1.96M	-8.58M
	Operating Cash Flow
-176.70K	-256.31K	5.55M	-82.77K	-1.81M	-3.62M
	Investing Cash Flow
-303.49K	-328.33K	-965.82K	-209.77K	122.77K	-2.39M
	Financing Cash Flow
-586.44K	-962.02K	-1.50M	-412.09K	2.37M	5.85M

CanadaBis Capital Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.07, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.27 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	64 Neutral	$12.85B	9.81	7.59%	16985.65%	12.30%	-7.71%
CANB	53 Neutral	C$6.22M	30.00	2.43%	―	-14.41%	-93.67%
PCLO	24 Underperform	$7.69M	―	184.66%	―	125.70%	47.09%

CanadaBis Capital Corporate Events

CanadaBis Capital Ends Arrangement Agreement with Simply Solventless

CanadaBis Capital Inc. has terminated its Arrangement Agreement with Simply Solventless Concentrates Ltd., which was intended for SSC to acquire all issued and outstanding shares of CanadaBis. The decision to terminate was due to a ‘Material Adverse Change’ concerning SSC, deemed in the best interest of CanadaBis shareholders and stakeholders. Consequently, all voting and support agreements related to the transaction have been automatically terminated, and a special meeting of CanadaBis shareholders has been canceled.

CanadaBis Capital Completes $4 Million Financing to Boost Cannabis Growth

CanadaBis Capital Inc. has successfully closed the final tranche of its brokered private placement, raising a total of $4,035,000 through the issuance of unsecured convertible debentures. This financing move, facilitated by Research Capital Corporation, is expected to bolster CanadaBis’s financial position and support its growth strategies in the cannabis industry, particularly in the concentrates segment. The debentures, which mature in 2029, offer a conversion option into common shares, providing flexibility for investors and potentially enhancing shareholder value.

CanadaBis Capital Secures $2.6 Million in First Tranche Financing

CanadaBis Capital Inc. has successfully closed the first tranche of its brokered private placement, raising $2.6 million through the issuance of unsecured convertible debentures. The debentures, which bear an interest rate of 11% per annum and mature in 2029, offer flexibility for conversion into common shares and potential redemption options. This financing move supports CanadaBis’s strategic growth initiatives, including a plan of arrangement with Simply Solventless Concentrates Ltd., although the financing is not contingent upon the arrangement’s completion. The successful closing of this tranche indicates strong investor confidence in CanadaBis’s market positioning and future prospects.

CanadaBis Capital Reports Strong Q2 2025 Financial Results

CanadaBis Capital Inc. reported strong financial results for the second quarter of 2025, with gross revenue reaching $9 million, marking a $2 million increase from the previous year. The company’s adjusted EBITDA stood at $434,158, reflecting effective cost-control measures and operational efficiency. CanadaBis continues to focus on growth and optimizing margins, implementing cost-saving initiatives and exploring new product offerings to strengthen its market position in a competitive cannabis industry.

CanadaBis Capital Upsizes Convertible Debenture Financing to $4.5 Million

CanadaBis Capital Inc. has announced an increase in its brokered private placement of unsecured convertible debentures to $4.5 million due to strong investor demand. The debentures, which bear an interest rate of 11% per annum and are convertible into common shares, will mature 48 months from the closing date. This financing move is part of CanadaBis’s strategy to expand its operations, and it coincides with a planned arrangement with Simply Solventless Concentrates Ltd., though the financing is not contingent on this arrangement. The announcement highlights CanadaBis’s efforts to strengthen its financial position and expand its market presence in the cannabis industry.

Simply Solventless Acquires CanadaBis to Form Leading Cannabis Producer

Simply Solventless Concentrates Ltd. (SSC) has entered into an agreement to acquire CanadaBis Capital Inc. through an all-share deal, positioning the combined entity as a leading producer in the Canadian cannabis concentrates and preroll markets. This strategic move is expected to significantly boost SSC’s revenue and profitability, while CanadaBis aims to leverage the merger to achieve sustainable competitive advantage and create substantial value for shareholders.